跳至主要内容
临床试验/jRCT2071240014
jRCT2071240014已完成不适用

ONO-1110-03 : An Open-label Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-1110 after Single Oral Administration in Japanese Healthy Adult Male Subjects

Ono Pharmaceutical Co.,LTD0 个研究点目标入组 6 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
6
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Crossover Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
18age old over 至 45age old under(—)
性别
Male

入选标准

  • Healthy Japanese adult males
  • The subject is aged 18 to 45 years, inclusive, at the time of signing the informed consent form.
  • The subject has a BMI of 18.5 kg/m2 or more and less than 25.0 kg/m2 (rounded down to 2 decimal places) at screening.

排除标准

  • An individual who is receiving treatment for or has a history of a respiratory, cardiovascular, psychiatric, neurological, gastrointestinal, immunological, hepatic, renal, hematopoietic, endocrine, or other disease
  • Subjects with current or perious history of severe allergy to drugs or food
  • The subject who is judged by the investigator or subinvestigator to be inappropriate as a subject of this study based on the results of screening tests

结局指标

主要结局

-

Plasma ONO-1110 concentrations and pharmacokinetic parameters

次要结局

  • Adverse events(after administration of investigational product until the end of final examination)

研究者

相似试验